Results 241 to 250 of about 2,563,992 (349)
Free energy perturbations in enzyme kinetic models reveal cryptic epistasis. [PDF]
Buda K, Tokuriki N.
europepmc +1 more source
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena +15 more
wiley +1 more source
What teleology (if any) does the Organisational Approach naturalise? [PDF]
Cuciniello RR.
europepmc +1 more source
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen +9 more
wiley +1 more source
APMSR: an intelligent QA system for synthetic biology empowered by adaptive prompting and multi-source knowledge retrieval. [PDF]
Wang J, Cao Z, Tian Z, Sun B, Cheng L.
europepmc +1 more source
Insights into a long life without cancer: The case of the bowhead whale
Long‐lived, large‐bodied organisms have evolved powerful anticancer mechanisms that preserve cellular and tissue integrity across extended lifespans. A recent study by Firsanov et al. shows that greater genome stability is a key factor underlying the remarkable longevity and cancer resistance of one such species, the bowhead whale.
Inés Paniagua, Johanna A. Joyce
wiley +1 more source
CABIF-Net: Robust Confidence-Based Audio-Visual Fusion for Fine-Grained Bird Recognition. [PDF]
Li Z, Zhang Y, Lv D, Yu Y.
europepmc +1 more source
Mechanical Transduction and the Dark Energy of Biology [PDF]
openaire +2 more sources
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source

